Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Hraber

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
Hepatology (Baltimore, Md.)|October 16, 2007
Evidence for human leukocyte antigen heterozygote advantage against hepatitis C virus infectionPeter Hraber, Carla Kuiken, Karina Yusim
Nucleic Acids Research|November 21, 2007
The hepatitis C sequence database in Los AlamosCarla Kuiken, Peter Hraber, James Thurmond, et al.
Immunological Reviews|January 31, 2017
Polyvalent vaccine approaches to combat HIV-1 diversityBette Korber, Peter Hraber, Kshitij Wagh, et al.
Elife|January 20, 2018
A single, continuous metric to define tiered serum neutralization potency against HIVPeter Hraber, Bette Korber, Kshitij Wagh, et al.
Vaccine|October 20, 2018
Amphiphilic block copolymer delivery of a DNA vaccine against Zika virusPeter Hraber, Steven Bradfute, Elizabeth Clarke, et al.
The Journal of General Virology|August 30, 2008
Classification of hepatitis C virus and human immunodeficiency virus-1 sequences with the branching indexPeter Hraber, Carla Kuiken, Mark Waugh, et al.
Vaccines|June 7, 2020
Vaccine Advances against Venezuelan, Eastern, and Western Equine Encephalitis VirusesZachary R Stromberg, Will Fischer, Steven B Bradfute, et al.
Frontiers in Immunology|March 24, 2018
Many Routes to an Antibody Heavy-Chain CDR3: Necessary, Yet Insufficient, for Specific BindingSara D'Angelo, Fortunato Ferrara, Leslie Naranjo, et al.
AIDS (London, England)|December 24, 2013
Prevalence of broadly neutralizing antibody responses during chronic HIV-1 infectionPeter Hraber, Michael S Seaman, Robert T Bailer, et al.
BMC Bioinformatics|August 23, 2013
A multiple-alignment based primer design algorithm for genetically highly variable DNA targetsJohanna Brodin, Mohan Krishnamoorthy, Gayathri Athreya, et al.
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
Hepatology (Baltimore, Md.)|October 16, 2007
Evidence for human leukocyte antigen heterozygote advantage against hepatitis C virus infectionPeter Hraber, Carla Kuiken, Karina Yusim
Nucleic Acids Research|November 21, 2007
The hepatitis C sequence database in Los AlamosCarla Kuiken, Peter Hraber, James Thurmond, et al.
Immunological Reviews|January 31, 2017
Polyvalent vaccine approaches to combat HIV-1 diversityBette Korber, Peter Hraber, Kshitij Wagh, et al.
Elife|January 20, 2018
A single, continuous metric to define tiered serum neutralization potency against HIVPeter Hraber, Bette Korber, Kshitij Wagh, et al.
Vaccine|October 20, 2018
Amphiphilic block copolymer delivery of a DNA vaccine against Zika virusPeter Hraber, Steven Bradfute, Elizabeth Clarke, et al.
The Journal of General Virology|August 30, 2008
Classification of hepatitis C virus and human immunodeficiency virus-1 sequences with the branching indexPeter Hraber, Carla Kuiken, Mark Waugh, et al.
Vaccines|June 7, 2020
Vaccine Advances against Venezuelan, Eastern, and Western Equine Encephalitis VirusesZachary R Stromberg, Will Fischer, Steven B Bradfute, et al.
Frontiers in Immunology|March 24, 2018
Many Routes to an Antibody Heavy-Chain CDR3: Necessary, Yet Insufficient, for Specific BindingSara D'Angelo, Fortunato Ferrara, Leslie Naranjo, et al.
AIDS (London, England)|December 24, 2013
Prevalence of broadly neutralizing antibody responses during chronic HIV-1 infectionPeter Hraber, Michael S Seaman, Robert T Bailer, et al.
BMC Bioinformatics|August 23, 2013
A multiple-alignment based primer design algorithm for genetically highly variable DNA targetsJohanna Brodin, Mohan Krishnamoorthy, Gayathri Athreya, et al.
Pageof 5